Safety and Efficacy of Senolytic UBX1325 in Diabetic Macular Edema

/in , /by

https://evidence.nejm.org/doi/full/10.1056/EVIDoa2400009

You might also like
Cellular Senescence Is Associated With Human Retinal Microaneurysm Formation During Aging
Pathological angiogenesis in retinopathy engages cellular senescence and is amenable to therapeutic elimination via BCL-xL inhibition
Cellular Senescence Is Associated With Human Retinal Microaneurysm Formation During Aging
Senescence-associated secretory phenotype contributes to pathological angiogenesis in retinopathy
Therapeutic targeting of cellular senescence in diabetic macular edema: preclinical and phase 1 trial results
UBX1325, a small molecule inhibitor of Bcl-xL, attenuates vascular dysfunction in two animal models of retinopathy
Neutrophil extracellular traps target senescent vasculature for tissue remodeling in retinopathy

©2025 Unity Biotechnology. All Rights Reserved. Terms & Conditions | Privacy Policy

Therapeutic targeting of cellular senescence in diabetic macular edema: preclinical...